These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen. Ellis V, Whawell SA, Werner F, Deadman JJ. Biochemistry; 1999 Jan 12; 38(2):651-9. PubMed ID: 9888805 [Abstract] [Full Text] [Related]
12. Differential expression of a truncated form of the urokinase-type plasminogen-activator receptor in normal and tumor thyroid cells. Ragno P, Montuori N, Covelli B, Hoyer-Hansen G, Rossi G. Cancer Res; 1998 Mar 15; 58(6):1315-9. PubMed ID: 9515821 [Abstract] [Full Text] [Related]
13. Plasminogen activation in bullous pemphigoid immunohistology reveals urokinase type plasminogen activator, its receptor and plasminogen activator inhibitor type-2 in lesional epidermis. Schaefer BM, Jaeger C, Drepper E, Kramer MD. Autoimmunity; 1996 Mar 15; 23(3):155-64. PubMed ID: 8879451 [Abstract] [Full Text] [Related]
14. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. Mazzieri R, Masiero L, Zanetta L, Monea S, Onisto M, Garbisa S, Mignatti P. EMBO J; 1997 May 01; 16(9):2319-32. PubMed ID: 9171346 [Abstract] [Full Text] [Related]
15. Regulation of human squamous cell carcinoma plasma membrane associated urokinase plasminogen activator by epidermal growth factor. Niedbala MJ, Bajetta S, Carbone R, Sartorelli AC. Cancer Commun; 1990 May 01; 2(9):317-24. PubMed ID: 2169831 [Abstract] [Full Text] [Related]
16. Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins. Reuning U, Magdolen V, Hapke S, Schmitt M. Biol Chem; 2003 Aug 01; 384(8):1119-31. PubMed ID: 12974381 [Abstract] [Full Text] [Related]
17. The urokinase-receptor (CD87) is expressed in cells of the megakaryoblastic lineage. Wohn KD, Kanse SM, Deutsch V, Schmidt T, Eldor A, Preissner KT. Thromb Haemost; 1997 Mar 01; 77(3):540-7. PubMed ID: 9066008 [Abstract] [Full Text] [Related]
18. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro. Gallicchio MA, Kaun C, Wojta J, Binder B, Bach LA. J Cell Physiol; 2003 Oct 01; 197(1):131-8. PubMed ID: 12942549 [Abstract] [Full Text] [Related]
19. Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87). Magdolen V, Bürgle M, de Prada NA, Schmiedeberg N, Riemer C, Schroeck F, Kellermann J, Degitz K, Wilhelm OG, Schmitt M, Kessler H. Biol Chem; 2001 Aug 01; 382(8):1197-205. PubMed ID: 11592401 [Abstract] [Full Text] [Related]
20. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR. Plesner T, Behrendt N, Ploug M. Stem Cells; 1997 Aug 01; 15(6):398-408. PubMed ID: 9402652 [Abstract] [Full Text] [Related] Page: [Next] [New Search]